147 related articles for article (PubMed ID: 11759064)
1. Tissue microarray technique in soft tissue sarcoma: immunohistochemical Ki-67 expression in malignant fibrous histiocytoma.
Engellau J; Akerman M; Anderson H; Domanski HA; Rambech E; Alvegård TA; Nilbert M
Appl Immunohistochem Mol Morphol; 2001 Dec; 9(4):358-63. PubMed ID: 11759064
[TBL] [Abstract][Full Text] [Related]
2. Standardizing evaluation of sarcoma proliferation- higher Ki-67 expression in the tumor periphery than the center.
Fernebro J; Engellau J; Persson A; Rydholm A; Nilbert M
APMIS; 2007 Jun; 115(6):707-12. PubMed ID: 17550378
[TBL] [Abstract][Full Text] [Related]
3. Expression of proliferating cell nuclear antigen (PCNA) and Ki-67 in soft tissue sarcoma. Is prognostic significance histotype-specific?
Choong PF; Akerman M; Willén H; Andersson C; Gustafson P; Alvegård T; Rydholm A
APMIS; 1995 Nov; 103(11):797-805. PubMed ID: 8546844
[TBL] [Abstract][Full Text] [Related]
4. Expression profiling using tissue microarray in 211 malignant fibrous histiocytomas confirms the prognostic value of Ki-67.
Engellau J; Persson A; Bendahl PO; Akerman M; Domanski HA; Bjerkehagen B; Lilleng P; Weide J; Rydholm A; Alvegård TA; Nilbert M
Virchows Arch; 2004 Sep; 445(3):224-30. PubMed ID: 15309631
[TBL] [Abstract][Full Text] [Related]
5. Proliferative activity (MIB-1 index) is an independent prognostic parameter in patients with high-grade soft tissue sarcomas of subtypes other than malignant fibrous histiocytomas: a retrospective immunohistological study including 216 soft tissue sarcomas.
Jensen V; Sørensen FB; Bentzen SM; Ladekarl M; Nielsen OS; Keller J; Jensen OM
Histopathology; 1998 Jun; 32(6):536-46. PubMed ID: 9675593
[TBL] [Abstract][Full Text] [Related]
6. Pleomorphic malignant fibrous histiocytoma: fact or fiction? A critical reappraisal based on 159 tumors diagnosed as pleomorphic sarcoma.
Fletcher CD
Am J Surg Pathol; 1992 Mar; 16(3):213-28. PubMed ID: 1317996
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of immunohistochemical parameters as prognostic markers in malignant fibrous histiocytoma.
Ahlén J; Weng WW; Brosjö O; Von Rosen A; Larsson O; Larsson C
Oncol Rep; 2003; 10(5):1641-5. PubMed ID: 12883752
[TBL] [Abstract][Full Text] [Related]
8. FU-3 monoclonal antibody: a specific marker for malignant fibrous histiocytoma? An analysis of 32 malignant soft tissue and bone sarcomas.
Perez-Bacete MJ; Llombart-Bosch A
Virchows Arch; 1994; 424(3):243-7. PubMed ID: 8186889
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemistry of soft-tissue tumors. Possibilities and limitations in surgical pathology.
Miettinen M
Pathol Annu; 1990; 25 Pt 1():1-36. PubMed ID: 2153276
[No Abstract] [Full Text] [Related]
10. Validity and reproducibility of histologic diagnosis and grading for adult soft-tissue sarcomas.
Hasegawa T; Yamamoto S; Nojima T; Hirose T; Nikaido T; Yamashiro K; Matsuno Y
Hum Pathol; 2002 Jan; 33(1):111-5. PubMed ID: 11823981
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of augmented metallothionein (MT) expression correlated with Ki-67 antigen expression in selected soft tissue sarcomas.
Dziegiel P; Salwa-Zurawska W; Zurawski J; Wojnar A; Zabel M
Histol Histopathol; 2005 Jan; 20(1):83-9. PubMed ID: 15578426
[TBL] [Abstract][Full Text] [Related]
12. An unusual soft tissue tumor with features of angiomatoid malignant fibrous histiocytoma composed of bimodal CD34 and factor XIIIa positive dendritic cell subsets. CD34 and factor XIIIa in angiomatoid MFH.
Silverman JS; Lomvardias S
Pathol Res Pract; 1997; 193(1):51-8; discussion 59-60. PubMed ID: 9112273
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical detection of bone morphogenetic proteins in bone and soft-tissue sarcomas.
Yoshikawa H; Rettig WJ; Lane JM; Takaoka K; Alderman E; Rup B; Rosen V; Healey JH; Huvos AG; Garin-Chesa P
Cancer; 1994 Aug; 74(3):842-7. PubMed ID: 8039112
[TBL] [Abstract][Full Text] [Related]
14. Expression of stem cell factor and lack of c-kit expression in malignant fibrous histiocytoma of soft tissues.
Yamamoto T; Nakatani T; Marui T; Akisue T; Fujita I; Matsumoto K; Hitora T; Kawamoto T; Nagira K; Kurosaka M
Anticancer Res; 2003; 23(5b):4305-8. PubMed ID: 14666642
[TBL] [Abstract][Full Text] [Related]
15. Malignant fibrous histiocytoma of soft tissue: an abandoned diagnosis.
Randall RL; Albritton KH; Ferney BJ; Layfield L
Am J Orthop (Belle Mead NJ); 2004 Dec; 33(12):602-8. PubMed ID: 15641745
[TBL] [Abstract][Full Text] [Related]
16. Amphiregulin and epidermal growth factor receptor expression in human malignant fibrous histiocytoma of soft tissues.
Yamamoto T; Fujita I; Akisue T; Marui T; Nakatani T; Kawamoto T; Hitora T; Nagira K; Matsumoto K; Kurosaka M
Anticancer Res; 2004; 24(2C):1307-10. PubMed ID: 15154665
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the tissue microarray technique for immunohistochemical analysis in rectal cancer.
Fernebro E; Dictor M; Bendahl PO; Fernö M; Nilbert M
Arch Pathol Lab Med; 2002 Jun; 126(6):702-5. PubMed ID: 12033959
[TBL] [Abstract][Full Text] [Related]
18. Distribution of actin isoforms in sarcomas: an immunohistochemical study.
Roholl PJ; Elbers HR; Prinsen I; Claessens JA; van Unnik JA
Hum Pathol; 1990 Dec; 21(12):1269-74. PubMed ID: 2174404
[TBL] [Abstract][Full Text] [Related]
19. Prognostic implication of the p53 protein and Ki-67 antigen immunohistochemistry in malignant fibrous histiocytoma.
Yang P; Hirose T; Hasegawa T; Seki K; Sano T; Hizawa K
Cancer; 1995 Aug; 76(4):618-25. PubMed ID: 8625155
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors in soft tissue sarcoma. Tissue microarray for immunostaining, the importance of whole-tumor sections and time-dependence.
Engellau J
Acta Orthop Scand Suppl; 2004 Dec; 75(314):2 p preceding table of contents-52, backcover. PubMed ID: 15678700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
